Jackson Creek Investment Advisors LLC Invests $1.43 Million in ICU Medical, Inc. (NASDAQ:ICUI)

Jackson Creek Investment Advisors LLC acquired a new position in ICU Medical, Inc. (NASDAQ:ICUI) in the 4th quarter, Holdings Channel.com reports. The firm acquired 9,204 shares of the medical instruments supplier’s stock, valued at approximately $1,428,000.

Other institutional investors also recently bought and sold shares of the company. Amalgamated Bank increased its position in ICU Medical by 13.1% in the third quarter. Amalgamated Bank now owns 7,067 shares of the medical instruments supplier’s stock worth $1,288,000 after buying an additional 816 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of ICU Medical by 24.6% during the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock valued at $23,130,000 after acquiring an additional 25,031 shares during the period. Equitable Trust Co. increased its holdings in ICU Medical by 2.2% in the 3rd quarter. Equitable Trust Co. now owns 5,213 shares of the medical instruments supplier’s stock worth $950,000 after acquiring an additional 112 shares in the last quarter. Atria Investments Inc bought a new stake in ICU Medical during the 3rd quarter worth approximately $228,000. Finally, Crossmark Global Holdings Inc. purchased a new position in ICU Medical during the third quarter valued at approximately $313,000. 96.10% of the stock is owned by institutional investors.

ICU Medical Stock Down 0.2 %

Shares of ICUI stock opened at $141.97 on Friday. The company’s fifty day simple moving average is $159.29 and its two-hundred day simple moving average is $165.76. ICU Medical, Inc. has a 52 week low of $93.36 and a 52 week high of $196.26. The stock has a market cap of $3.48 billion, a P/E ratio of -31.07 and a beta of 0.73. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

Analyst Ratings Changes

ICUI has been the subject of several recent analyst reports. Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price for the company in a report on Wednesday, December 11th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Finally, KeyCorp boosted their price target on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, ICU Medical presently has an average rating of “Moderate Buy” and an average target price of $199.67.

Insider Transactions at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the completion of the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. This trade represents a 1.30 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 6.70% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.